150 related articles for article (PubMed ID: 19883829)
1. Editorial comment.
Berglund RK
Urology; 2009 Nov; 74(5):1083; author reply 1084. PubMed ID: 19883829
[No Abstract] [Full Text] [Related]
2. Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer.
Maffezzini M; Campodonico F; Puntoni M; Martelli A; Mattioli F
Urology; 2009 Nov; 74(5):1078-83. PubMed ID: 19773039
[TBL] [Abstract][Full Text] [Related]
3. Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.
Palou J; Carcas A; Segarra J; Duque B; Salvador J; Garcia-Ribas I; Villavicencio H
J Urol; 2004 Aug; 172(2):485-8. PubMed ID: 15247710
[TBL] [Abstract][Full Text] [Related]
4. Perioperative chemotherapy: when to use it, what to use, and why.
Johnson DC; Pruthi RS; Woods ME
Urol Clin North Am; 2013 May; 40(2):183-95. PubMed ID: 23540777
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
Campodonico F; Mattioli F; Manfredi V; Capponi G; Pasquini P; Martelli A; Maffezzini M
Anticancer Res; 2007; 27(2):1179-83. PubMed ID: 17465260
[TBL] [Abstract][Full Text] [Related]
6. Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.
Mattioli F; Curotto A; Manfredi V; Gosmar M; Garbero C; Ambruosi C; Carmignani G; Martelli A
Anticancer Res; 2005; 25(3c):2493-6. PubMed ID: 16080482
[TBL] [Abstract][Full Text] [Related]
7. Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.
De Berardinis E; Antonini G; Peters GJ; Loves WJ; Van der Born K; Codacci-Pisanelli G; Di Silverio F
BJU Int; 2004 Mar; 93(4):491-4. PubMed ID: 15008715
[TBL] [Abstract][Full Text] [Related]
8. Microemulsions for intravesical delivery of gemcitabine.
Tsai YH; Hsieh YH; Huang YB; Chang JS; Huang CT; Wu PC
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1461-5. PubMed ID: 21048337
[TBL] [Abstract][Full Text] [Related]
9. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
Gontero P; Marini L; Frea B
BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
[No Abstract] [Full Text] [Related]
10. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.
Campodonico F; Maffezzini M
Urology; 2005 Nov; 66(5):1141-2; author reply 1142. PubMed ID: 16286156
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs.
Witjes JA; Vriesema JL; van der Heijden AG; Peters GJ; Schalken JA
Eur Urol; 2003 Nov; 44(5):615-9. PubMed ID: 14572765
[TBL] [Abstract][Full Text] [Related]
12. Intravesical gemcitabine: a phase 1 and pharmacokinetic study.
Witjes JA; van der Heijden AG; Vriesema JL; Peters GJ; Laan A; Schalken JA
Eur Urol; 2004 Feb; 45(2):182-6. PubMed ID: 14734004
[TBL] [Abstract][Full Text] [Related]
13. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.
Oh KS; Soto DE; Smith DC; Montie JE; Lee CT; Sandler HM
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):511-7. PubMed ID: 18977098
[TBL] [Abstract][Full Text] [Related]
14. Intravesical therapy for superficial cancer: need for more options.
Crawford ED
J Clin Oncol; 2002 Aug; 20(15):3185-6. PubMed ID: 12149286
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.
Bassi P; De Marco V; Tavolini IM; Longo F; Pinto F; Zucchetti M; Crucitta E; Marini L; Dal Moro F
Urol Int; 2005; 75(4):309-13. PubMed ID: 16327296
[TBL] [Abstract][Full Text] [Related]
16. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.
Sternberg IA; Dalbagni G; Chen LY; Donat SM; Bochner BH; Herr HW
J Urol; 2013 Nov; 190(5):1686-91. PubMed ID: 23665400
[TBL] [Abstract][Full Text] [Related]
17. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.
Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F
Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745
[TBL] [Abstract][Full Text] [Related]
18. Combination Intravesical Therapy.
Brooks NA; O'Donnell MA
Urol Clin North Am; 2020 Feb; 47(1):83-91. PubMed ID: 31757303
[TBL] [Abstract][Full Text] [Related]
19. [Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?].
Lebret T
Prog Urol; 2008 May; 18 Suppl 5():S111-4. PubMed ID: 18585632
[TBL] [Abstract][Full Text] [Related]
20. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
Campodonico F; Canepa G; Capponi G; Bozzo L; Maffezzini M
Anticancer Res; 2005; 25(3c):2381-4. PubMed ID: 16080464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
